Medifast/$MED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medifast
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Ticker
$MED
Sector
Primary listing
NYSE
Employees
380
Headquarters
Website
Medifast Metrics
BasicAdvanced
$104M
-
-$1.70
0.54
-
Price and volume
Market cap
$104M
Beta
0.54
52-week high
$15.46
52-week low
$9.22
Average daily volume
270K
Financial strength
Current ratio
4.694
Quick ratio
3.894
Long term debt to equity
3.062
Total debt to equity
5.376
Profitability
EBITDA (TTM)
0.029
Gross margin (TTM)
71.33%
Net profit margin (TTM)
-4.84%
Operating margin (TTM)
-3.68%
Effective tax rate (TTM)
-231.12%
Revenue per employee (TTM)
$1,020,000
Management effectiveness
Return on assets (TTM)
-3.34%
Return on equity (TTM)
-9.13%
Valuation
Price to revenue (TTM)
0.286
Price to book
0.52
Price to tangible book (TTM)
0.52
Price to free cash flow (TTM)
88.359
Free cash flow yield (TTM)
1.13%
Free cash flow per share (TTM)
0.114
Growth
Revenue change (TTM)
-35.96%
Earnings per share change (TTM)
-994.94%
3-year revenue growth (CAGR)
-37.74%
10-year revenue growth (CAGR)
3.53%
3-year earnings per share growth (CAGR)
-48.88%
10-year earnings per share growth (CAGR)
0.24%
What the Analysts think about Medifast
Analyst ratings (Buy, Hold, Sell) for Medifast stock.
Medifast Financial Performance
Revenues and expenses
Medifast Earnings Performance
Company profitability
Medifast News
AllArticlesVideos
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
Business Wire·4 weeks ago
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
Business Wire·4 weeks ago
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medifast stock?
Medifast (MED) has a market cap of $104M as of March 17, 2026.
What is the P/E ratio for Medifast stock?
The price to earnings (P/E) ratio for Medifast (MED) stock is 0 as of March 17, 2026.
Does Medifast stock pay dividends?
No, Medifast (MED) stock does not pay dividends to its shareholders as of March 17, 2026.
When is the next Medifast dividend payment date?
Medifast (MED) stock does not pay dividends to its shareholders.
What is the beta indicator for Medifast?
Medifast (MED) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.